Streetbeat News

Products Services

SNTI

Senti Biosciences (NASDAQ:SNTI) has announced a strategic collaboration with China-based biotech company Celest Therapeutics for the clinical development of SENTI-301A, a therapy for solid tumors, in China. Celest will lead clinical development, operations, and manufacturing with technical support from Senti Bio. The first patient is expected to be enrolled in China in 1H 2024. Senti Bio could receive up to $156 million in milestone payments and potential tiered royalty payments. Senti Bio retains all commercialization rights outside of mainland China, Hong Kong, Macau, and Taiwan for SENTI-301A.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:41 pm

DKNG

A sports bettor won a $50,000 windfall on a 1,000-to-1 bet placed with DraftKings Inc (NASDAQ:DKNG) on the performance of Boston Celtics' backup point guard Payton Pritchard in a recent NBA game. The bettor wagered on Pritchard to achieve certain stats and the Celtics to win by a certain margin, all of which occurred. The Celtics are currently the favorite to win the 2023-2024 NBA Championship.

Portfolio Pulse from Chris Katje

November 06, 2023 | 9:36 pm

TFX

The FDA has identified a Class I recall of pressure injectable catheter kits due to mislabeling. The recall involves products from Teleflex and Arrow International.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:24 pm

LCID

Lucid Group, Inc. (NASDAQ:LCID) shares traded lower after the company announced discounts on its Air sedan due to weak demand for electric vehicles. The company is offering 'Air Credit' discounts in the U.S. and Canada. This is not the first time Lucid has announced price discounts, with a similar announcement made in August.

Portfolio Pulse from Ryan Gustafson

November 06, 2023 | 9:18 pm

LCID

TSLA

Lucid Motors, under the ticker LCID, has announced plans to adopt the North American Charging Standard (NACS), which will allow it access to over 15,000 Tesla Superchargers across North America by 2025. This move could potentially increase the appeal of Lucid's electric vehicles by alleviating range anxiety and providing more charging options for customers.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:15 pm

VTYX

Ventyx announced results from its Phase 2 trial of VTX958 in patients with moderate to severe plaque psoriasis. The trial met primary and key secondary endpoints, but the company expressed disappointment with the magnitude of efficacy.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 9:03 pm

PSQH

Donald Trump Jr. has tweeted about the 'one-cart checkout' feature being a game changer for PSQH and the Patriot economy. He mentioned that products can now be shopped directly from the official PSQ app.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 8:05 pm

AURA

Aura Biosciences, Inc. (NASDAQ:AURA) has received agreement from the U.S. Food and Drug Administration (FDA) for the design and planned analysis of its global Phase 3 clinical trial of bel-sar for the first-line treatment of adult patients with early-stage choroidal melanoma. The company also presented positive Phase 2 safety and efficacy data of bel-sar with 90% of patients at twelve months of follow-up showing tumor control and visual acuity preservation. Preliminary data from a Phase 1 trial in bladder cancer showed a clinical complete response in the first patient using a single dose of bel-sar with light activation.

Portfolio Pulse from Benzinga Newsdesk

November 06, 2023 | 8:01 pm

AYRWF

PNXP

The Trenton City Council has approved Ed Forchion, also known as NJWeedman, to open a legal cannabis dispensary in New Jersey. Meanwhile, the Garden Greenz Dispensary opened in Jersey City and the first medical cannabis dispensary, Terrapin Care Station, launched in Hoboken. Stash Dispensaries announced a meet and greet event with Vic Mensa at its Illinois location. Pineapple Express Cannabis Company (OTC:PNXP) opened a dispensary in Hollywood, California, and AYR Wellness Inc. (CSE:AYR) (OTCQX:AYRWF) announced two new retail locations in Ohio.

Portfolio Pulse from Jelena Martinovic

November 06, 2023 | 8:01 pm

AMZN

A recent update to 'Baldur's Gate 3', a role-playing game developed by Larian Studios, has altered the game's romance mechanics, impacting the sex speedrunning community. The game, which debuted on Amazon's Twitch and Valve's Steam platforms, quickly gained popularity, reaching 340,000 concurrent players on Steam and around 480,000 viewers on Twitch.

Portfolio Pulse from Franca Quarneti

November 06, 2023 | 7:47 pm